Cerebral Therapeutics, Inc
Neurexis Therapeutics, based in Aurora, CO, is a pioneering biotech company dedicated to addressing the significant impact of stroke and cardiac arrest on human health. With a focus on neuroprotective innovation, Neurexis aims to reduce neuronal death and cognitive impairment caused by the loss of blood flow to the brain, offering a promising solution to an unmet medical need.
By developing tatCN19o, an optimized peptide with proven efficacy and safety in animal models, Neurexis Therapeutics is at the forefront of advancing a potential FDA-approved neuroprotective treatment that can greatly improve the quality of life for patients and alleviate the burden on healthcare systems both domestically and internationally.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.